Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Circulation|October 6, 2010
Conditional overexpression of neuronal nitric oxide synthase is cardioprotective in ischemia/reperfusionNatalie Burkard, Tatjana Williams, Martin Czolbe, et al.
International Journal of Cardiology|March 26, 2022
Multicenter comparison of latest-generation balloon-expandable versus self-expanding transcatheter heart valves: Ultra versus EvolutTobias Rheude, Costanza Pellegrini, Abdelhakim Allali, et al.
European Journal of Heart Failure|March 11, 2020
Cardiac iron concentration in relation to systemic iron status and disease severity in non-ischaemic heart failure with reduced ejection fractionValentin G Hirsch, Jörn Tongers, Julia Bode, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|April 28, 2023
Multicenter comparison of transcatheter aortic valve implantation with the self-expanding ACURATE neo2 versus Evolut PRO transcatheter heart valvesTobias Rheude, Costanza Pellegrini, Martin Landt, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 28, 2021
Impact of anemia on short-term outcomes after TAVR: A subgroup analysis from the BRAVO-3 randomized trialVictor Razuk, Anton Camaj, Davide Cao, et al.
Circulation|August 10, 2021
Myeloid-Derived Growth Factor Protects Against Pressure Overload-Induced Heart Failure by Preserving Sarco/Endoplasmic Reticulum Ca<sup>2+</sup>-ATPase Expression in CardiomyocytesMortimer Korf-Klingebiel, Marc R Reboll, Felix Polten, et al.
International Journal of Cardiology|October 22, 2019
Impact of diabetes mellitus on short term vascular complications after TAVR: Results from the BRAVO-3 randomized trialRidhima Goel, David Power, Didier Tchetche, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 10, 2023
Impact of coronary artery disease on clinical outcomes after TAVR: Insights from the BRAVO-3 randomized trialDaniel Feldman, Davide Cao, Samantha Sartori, et al.
Pageof 3